✦ LIBER ✦

Trend of Histone Deacetylase Inhibitors in Cancer Therapy: Isoform Selectivity or Multitargeted Strategy

✍ Scribed by Zhang, Lei; Han, Yantao; Jiang, Qixiao; Wang, Chunbo; Chen, Xuehong; Li, Xiaoguang; Xu, Fuming; Jiang, Yuqi; Wang, Qiang; Xu, Wenfang

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histone Deacetylase Inhibitors in Cancer

✍ Lane, Andrew A. (author);Chabner, Bruce A. (author) 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 156 KB

Histone Deacetylase Inhibitors in Cancer

✍ Lane, Andrew A. (author);Chabner, Bruce A. (author) 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 156 KB

Histone deacetylase inhibitors in the th

✍ Lee, Ju-Hee; Marks, Paul A 📂 Article 📅 2010 🏛 Future Medicine 🌐 English ⚖ 655 KB

New clinical developments in histone dea

✍ Shundong Cang; Yuehua Ma; Delong Liu 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 309 KB

Histone deacetylase inhibitors: Mechanis

✍ Jennifer S. Carew; Francis J. Giles; Steffan T. Nawrocki 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 429 KB

Histone deacetylase inhibitors as a new

✍ Oronza Antonietta Botrugno; Fabio Santoro; Saverio Minucci 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 242 KB